TiRNA-Gly-GCC-002 is associated with progression in patients with hepatocellular carcinoma.

导出 OA

翻译打印收藏纠错

作者： Lili,Wu ^[1] ; Lijiang,Zhang ^[2] ; Jie,Cao ^[3] ; Yunpeng,Sun ^[4] ; Jiajia,Zhang ^[5] ; Liang,Shi ^[6] ; Yong,Xia ^[7]

作者单位： Department of Clinical Transfusion, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. ^[1] School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China. ^[2] Translational Medicine Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. ^[3] Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. ^[4] Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. ^[5] School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.;Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. ^[6] Department of Clinical Medical Laboratory, Peking University Shenzhen Hospital, Shenzhen, China. ^[7]

关键词 hepatocellular carcinoma (HCC)nomogram predict prognosis tiRNA-Gly-GCC-002

DOI 10.21037/tcr-24-644

PMID 39430835

发布时间 2024-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交